Phillip Ordoukhanian

Scripps Research Institute

Papers

2

Total Citations

15

H-Index

2

About

Phillip Ordoukhanian is a researcher specializing in peptide microarray technology and immunological applications, with a particular focus on developing accessible and cost-effective tools for biomedical research. His most recognized contribution centers on the innovation of low-cost peptide microarrays designed for mapping continuous antibody epitopes — a technique critical for understanding how antibodies recognize and bind to their target proteins, with broad implications for vaccine development, diagnostics, and therapeutic antibody research. Ordoukhanian's work addresses a significant practical barrier in the field by making high-throughput epitope mapping more economically feasible, thereby democratizing access to sophisticated immunological assays for laboratories with limited resources. His 2015 publication on this methodology has garnered 12 citations, demonstrating meaningful uptake within the research community, and the continued relevance of this work is evidenced by a subsequent 2022 publication revisiting the topic. This sustained engagement suggests ongoing refinement and advocacy for these accessible technologies. For students and researchers entering the fields of proteomics, immunology, or diagnostic tool development, Ordoukhanian's contributions offer a valuable example of how practical engineering innovations can meaningfully advance scientific accessibility and discovery.

Research Focus

Key Achievements

2
H-Index
2
Papers
15
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Low-Cost Peptide Microarrays for Mapping Continuous Antibody Epitopes
12 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Scripps Research Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 6 days ago